WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Tuesday, June 19, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email


Global Anti-inflammatory Therapeutics Market, 2016-2026: Market Projected to US$ 130.6 Bn by 2026 with CAGR of 8.5%
Wednesday, June 13, 2018

DUBLIN, June 13, 2018 /PRNewswire/ --

The "Global Anti-inflammatory Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Anti-inflammatory therapeutics market projected to US$ 130.6 Bn by 2026 with CAGR of 8.5% throughout the forecast period from 2018 to 2026.

Biologics and immune selective anti-inflammatory derivatives (ImSAIDs) are the promising drugs classes that will play the main role in the market. Global anti-inflammatory therapeutics market from 2018-2026 study is based on exhaustive analysis with insights from industry stakeholders. The detailed study incorporates the market landscape and its growth scenarios for the forecasting period from 2018-2026.

According to World Health Organization (WHO), around 235 Mn individuals experience the ill effects of asthma around the globe. Symptomatic help amid the inflammation gives alleviation to the patients suffering from inflammatory diseases. In spite of the fact that there are numerous anti-inflammatory drugs present in the market, still, there is an essential requirement for better and novel anti-inflammatory therapeutics drugs with slighter side effects and improved efficacy.

Based on the drug types, the global anti-inflammatory therapeutics market is segmented into biologics, corticosteroids, immune selective anti-inflammatory derivatives (ImSAIDs), and non-steroidal anti-inflammatory drugs (NSAIDs); additionally, the indication studied in this report are categorized into COPD, multiple sclerosis, IBD, psoriatic arthritis, gout, and Others (Osteoarthritis, Systemic Lupus, Psoriasis). Rising prevalence of inflammatory diseases and the strong drug pipeline would additionally boost the anti-inflammatory therapeutics market.

Geographically, overall anti-inflammatory therapeutics market is projected for Europe, Middle East and Africa, Asia Pacific, Latin America, and North America. As for the revenue share, in 2017, North America drives the global market and projected that the situation will remain steady amid the forecast period. However, the dominance of North America will be evidently challenged by the Asia Pacific. There are huge chances for market penetration in countries like Mexico, India, and China to the market occupiers at present having a hold in established countries. The need for anti-inflammatory therapeutics drugs has become prominent in the Asia Pacific due to rapid development of the economy, developing healthcare facilities and immense patient base.

Key Topics Covered:

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Segmentation
1.4. Research Methodology

Chapter 2. Executive Summary
2.1. Global Anti-inflammatory Therapeutics Market, by Drug Type, 2017 (US$ Bn)
2.2. Global Anti-inflammatory Therapeutics Market, by Indication, 2017 (US$ Bn)
2.3. Global Anti-inflammatory Therapeutics Market, by Geography, 2017 (US$ Bn)

Chapter 3. Global Anti-inflammatory Therapeutics Market Overview, 2016-2026 (US$ Bn)
3.1. Overview
3.2. Market Drivers
3.2.1. Growing Incidence Of Respiratory Diseases And Autoimmune Conditions
3.3. Challenges
3.3.1. Lack of Timely Diagnosis and Access to Care
3.4. Opportunities
3.4.1. Strong Pipeline Candidates
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Market Competition Assessment, 2017

Chapter 4. Global Anti-inflammatory Therapeutics Market, by Drug Type, 2016 - 2026 (US$ Bn)
4.1. Overview
4.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
4.3. Corticosteroids
4.4. Biologics
4.5. Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
4.6. Pipeline Analysis (Market estimations Till 2026)
4.6.1. Projected Sale of Phase III Drugs Estimated Till 2026 (US$ Bn)
4.6.1.1. ABT-494
4.6.1.2. ABBV-066
4.6.1.3. Cobitolimod
4.6.2. Qualitative Information on Phase II and I drugs

Chapter 5. Global Anti-inflammatory Therapeutics Market, by Indication, 2016 - 2026 (US$ Bn)
5.1. Overview
5.2. Rheumatoid Arthritis
5.3. Chronic obstructive pulmonary disease (COPD)
5.4. Multiple Sclerosis
5.5. Inflammatory bowel disease (IBD)
5.6. Psoriatic Arthritis
5.7. Gout
5.8. Others (Osteoarthritis, Systemic lupus, Psoriasis)

Chapter 6. Global Anti-inflammatory Therapeutics Market, by Geography, 2016 - 2026 (US$ Bn)

Chapter 7. Company Profiles

    --  Pfizer, Inc.
    --  Amgen, Inc.
    --  AstraZeneca plc
    --  Eli Lily and Company
    --  GlaxoSmithKline plc
    --  Johnson & Johnson
    --  Merck & Company, Inc.
    --  Novartis International AG
    --  AbbVie Inc
    --  F. Hoffmann-La Roche AG

For more information about this report visit https://www.researchandmarkets.com/research/4wfrkg/global?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-anti-inflammatory-therapeutics-market-2016-2026-market-projected-to-us-130-6-bn-by-2026-with-cagr-of-8-5-300665565.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav FCB Health Named "Healthcare Network of the Year" at 2018 Cannes Lions Health Festival | Jun 19, 2018
Nav Hexagon Acquires SPRING Technologies, Makers of Machine Tool Simulation and Verification Software | Jun 19, 2018
Nav Eltek Sets Earnings Release Date and Conference Call to Report First Quarter 2018 Results on June 27, 2018 | Jun 19, 2018
Nav Lycamobile UK Launches Innovative Loyalty Programme | Jun 19, 2018
Nav CUI Global Subsidiary Orbital U.K. Enters into Collaboration with Keele University for the Development of Technologies for Future Gas Networks | Jun 19, 2018
Nav Lessonly Launches Insights to Improve How Businesses Measure Training | Jun 19, 2018
Nav SDL Cracks Russian to English Neural Machine Translation | Jun 19, 2018
Nav Taste Republic's fresh gluten-free pastas now available to buy in stores and online | Jun 19, 2018
Nav Gold-backed Jinbi Token Joins Forces With Powerhouse Pillar Project | Jun 19, 2018
Nav Global Flat Glass Markets Report, 2016-2024: Intense Competition Characterizes Flat Glass Market - Xinyi Solar Leads the Market | Jun 18, 2018
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News